Articles by James Paton | Fortune

Skip to Content

NEW

A vastly improved search engine helps you find the latest on companies, business leaders, and news more easily.

SIGN IN

International
AstraZeneca revises vaccine efficacy down to 76% after criticism of U.S. trial data
By
James Paton,
Michelle Fay Cortez,
and others
March 25, 2021
Leadership
GlaxoSmithKline gets rid of Trump’s vaccine adviser Slaoui for sexual harassment
By
James Paton,
Riley Griffin,
and others
March 24, 2021
Health
University of Oxford finds AstraZeneca vaccine effective on British variant
By
Eric Pfanner,
James Paton,
and others
February 5, 2021
Health
How vaccine nationalism could extend the pandemic
By
James Paton
and
Bloomberg
January 31, 2021
Health
Public health officials warn about slow vaccine rollout as coronavirus variants multiply
By
James Paton
and
Bloomberg
January 18, 2021
Health
Drugmakers hit back at U.K. plan to delay the second dose of COVID vaccines
By
James Paton
and
Bloomberg
January 13, 2021
Health
AstraZeneca acquires rare-disease specialist Alexion in $39 billion deal
By
John Lauerman,
James Paton,
and others
December 13, 2020
International
Britons will roll up their sleeves on Tuesday for a COVID vaccine jab as the world anxiously watches
By
James Paton,
Suzi Ring,
and others
December 7, 2020
International
U.K. approves Pfizer COVID-19 vaccine and will start distributing it next week
By
James Paton
and
Bloomberg
December 2, 2020
Health
AstraZeneca eyes another global trial for its COVID vaccine following dosage blip
By
Suzi Ring,
James Paton,
and others
November 27, 2020
Health
Oxford says COVID-19 vaccine has produced strong immune response ahead of late-stage trial results
By
James Paton,
Suzi Ring,
and others
November 19, 2020
Health
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
By
Suzi Ring,
James Paton,
and others
November 5, 2020
International
To jumpstart the COVID vaccine race, the U.K. considers ‘challenge trials’ exposing people to the virus
By
James Paton
and
Bloomberg
September 24, 2020
Health
Weight loss and obesity drugs could help fight COVID-19, Novo Nordisk says
By
James Paton
and
Bloomberg
September 4, 2020
International
These countries aren’t waiting for a U.S., China, or U.K. COVID vaccine
By
James Paton
and
Bloomberg
August 26, 2020

1 - 15 of 24 results

1 - 15 of 24 results

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Personal Information | Ad Choices
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.